FDA
-
-
-
-
-
-
-
Delcath Systems Announces Two ASCO 2026 Investigator Initiated Trials-in-Progress Abstracts
-
-
-
-
-
-
-
Delcath CHEMOSAT therapy included in European uveal melanoma guidelines
-
-
-
-
-
-
-
Delcath Systems to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
-
-
-
-
-
-
-
Delcath Systems Announces Publication of 10-Year Single-Center Experience with Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma
-
-
-
-
-
-
-
Delcath Systems to Participate in Upcoming Investor Conferences
-
-
-
-
-
-
-
Delcath Systems trial results to be presented at ESMO 2025 congress
-
-
-
-
-
-
-
Delcath Systems to Participate at the Canaccord Genuity 45th Annual Growth Conference
-
328,148 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

